Leo International Precision Health AG Return on Equity (ROE) Growth & History (LEOW)

Leo International Precision Health AG's return on equity was −3.32% for fiscal 2025.

View full Leo International Precision Health AG company overview

Leo International Precision Health AG annual return on equity history

Leo International Precision Health AG annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−3.32%
20172017-12-31−333.33%−197.33 pp
20162016-12-31−136.00%+7.28 pp
20152015-12-31−143.28%−145.93 pp
20142014-12-312.64%+2.64 pp
20132013-12-310.00%−1.63 pp
20122012-12-311.63%+1.63 pp
20112011-12-310.00%

Leo International Precision Health AG return on equity trends

Between the periods ended 2011-12-31 and 2025-12-31, Leo International Precision Health AG's return on equity decreased from 0.00% to −3.32%, a change of −3.32 percentage points.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Leo International Precision Health AG source filings ↗

Community posts

It’s quiet here.

No posts about LEOW yet. Start the conversation.

Write the first post